The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study.
 
Edmond Michael Kwan
Honoraria - Astellas Pharma; Ipsen; Janssen; Research Review
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer; Roche
 
Moira Katherine Rushton
Honoraria - Gilead Sciences
Consulting or Advisory Role - Novartis; Pfizer; Viatris
Speakers' Bureau - AstraZeneca; Lilly
 
Wilson Tu
No Relationships to Disclose
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Bayer; Eisai; Ipsen; Janssen Oncology; Merck
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SignalChem (Inst)
Travel, Accommodations, Expenses - Eisai
 
Som D. Mukherjee
Consulting or Advisory Role - EMD Serono/Merck
Travel, Accommodations, Expenses - Amgen
 
Michael Ong
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Pfizer/EMD Serono; Sanofi
Research Funding - AstraZeneca
 
Michael Paul Kolinsky
Honoraria - Bayer; Janssen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Ipsen; Janssen; Merck
Research Funding - Janssen (Inst)
 
Zineb Hamilou
No Relationships to Disclose
 
Eric Winquist
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Ayala Pharmaceuticals (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Cristiano Ferrario
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Knight Pharmaceuticals; Merck; Novartis; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Novartis; Roche; Seagen
Speakers' Bureau - AstraZeneca; Knight Therapeutics; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bicycle Therapeutics (Inst); Immunomedics (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Zymeworks (Inst)
Expert Testimony - Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Lifecell Corporation; Roche
 
Robyn Jane Macfarlane
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genzyme; Janssen; Merck; Novartis Canada Pharmaceuticals Inc
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Muhammad Salim
No Relationships to Disclose
 
Di Maria Jiang
Honoraria - Amgen; Bayer; EMD Serono; Ipsen; Janssen Oncology
Consulting or Advisory Role - Bayer; Pfizer/EMD Serono
 
Dongsheng Tu
No Relationships to Disclose
 
James Hutchenreuther
No Relationships to Disclose
 
Matti Annala
No Relationships to Disclose
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Novartis (Inst); Repare Therapeutics (Inst)
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis
 
Alexander William Wyatt
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca Canada; Janssen; Merck
Consulting or Advisory Role - AstraZeneca
Research Funding - ESSA (Inst)